Submission of revised proceedings of the EGM held on 09th May, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has filed a revised version of the proceedings from its Extra Ordinary General Meeting held on 9th May 2025 through video conferencing, which ran from 3:35 PM to 3:58 PM and was attended by 26 members. The original outcome filing was submitted late on 10th May 2025 due to a delay in receiving the meeting recordings, and the company clarified this was not an intentional default. Two resolutions were transacted: a special resolution to confirm Mr. Lakshman Samala (DIN: 10783725) as Independent Director, and an ordinary resolution to confirm Mr. Jivamohan Divakar Valluri (DIN: 09218013) as Non-Executive Non-Independent Director. Remote e-voting was conducted via CDSL between 6th and 8th May 2025, with voting results to be announced within 48 hours of meeting conclusion.
This is a routine administrative re-filing of EGM minutes to fix a late submission; shareholders should note that two directors (one Independent, one Non-Executive) have been formally confirmed in their roles. No material business change, fundraising, or strategic decision was approved at this meeting.